Author:
Teixeira H.,Silva L.,Matias C.,Magalhães J. F. F.,Lyra J. M. A.,Magalhães V.,Melo H. R. L.,Jucá M. B.,Brito C. A. A.
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young J-AH, Wingard JR (2011) Executive summary: clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:427–431. doi: 10.1093/cid/ciq147
2. Montassier E, Batard E, Gastinne T, Potel G, Cochetière MF (2013) Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 32:841–850. doi: 10.1007/s10096-013-1819-7
3. Gea-Banacloche J (2013) Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies. ASH Educ Program Book 2013:414–422
4. Pfaffenbach B, Donhuijsen K, Pahnke J et al (1983) (1994) [Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients]. Med Klin Munich Ger 89:299–304
5. Hummel M, Warga C, Hof H, Hehlmann R, Buchheidt D (2009) Diagnostic yield of blood cultures from antibiotic-naive and antibiotically treated patients with haematological malignancies and high-risk neutropenia. Scand J Infect Dis 41:650–655. doi: 10.1080/00365540903062150
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献